SESSION 1: THE CLINICAL VALUE OF PLATELET RE-ACTIVITY TESTING - AN INTRODUCTION

↳ This is a section part of Moment: Platelet Function Testing

Add this Moment to your Passport

Learn from this moment and keep it forever.
FREE
Add To Passport

Preview

Summary

As a precursor to the discussion sessions of the Platelet Function Testing Round Table, held in Amsterdam in September 2013, Jeff Dahlen, Chief Scientific Officer of Accumetrics, delivers an insightful presentation on the The Clinical Value of Platelet Re-activity Testing.

Add this Moment to your Passport

Learn from this moment and keep it forever.
FREE
Add To Passport

Target Audience

This round table discussion is intended for an international audience, specifically interventional cardiologists, interventional radiologists and aligned healthcare professional involved with antiplatelet therapy.

The Round Table Event was supported by Accumetrics.

Learning Objectives

Designed to support the continuous education of practicing physicians, this roundtable shares leading opinion and addresses the following questions and key educational objectives:

  • Increase physician awareness of the multidisciplinary role of antiplatelet therapy
  • Increase understanding of the role of platelet function testing in high-risk PCI
  • Explain the emerging role of PFT in PAD
  • Assess the role of antiplatelets in neuro-endovascular procedures

Other Components in this Moment

Overview
SESSION 1: THE CLINICAL VALUE OF PLATELET RE-ACTIVITY TESTING - AN INTRODUCTION
SESSION 2: THE ROLE OF ANTIPLATELET THERAPIES IN NEURO-ENDOVASCULAR PROCEDURES
SESSION 3: PLATELET REACTIVITY TESTING - TREATMENT OPTIONS FOR HIGH-RISK PCI PATIENTS
SESSION 4: A REVIEW OF THE PROCEDURES IN PERIPHERAL INTERVENTION THAT REQUIRE ANTIPLATELET THERAPY
SESSION 5: BALANCING THE EFFICIENCY AND SAFETY OF ANTIPLATELET AGENTS - A CROSS-THERAPY DISCUSSION
Loading Simple Education